Within the tirzepatide treatment arm, the studys most common adverse effect, gastrointestinal disorders, occurred in 46.0% of patients who experienced a cardiorenal end point versus 41.4% of patients who did not
By acting on specific receptors in the brain, Wegovy helps to suppress appetite, increase feelings of fullness, and ultimately reduce calorie intake
This affordability model directly addresses why many people discontinuenot because semaglutide fails, but because branded options become unsustainable
By reducing inflammation and supporting cartilage repair, BPC-157 contributes to joint resilience and overall well-being
stop GLP-1 receptor agonists or tirzepatide if they do not help the person reach their individualised glycaemic targets and they are not being taken for their cardiovascular benefits
Limit very high-oxalate foods if your 24-hour urine shows excess oxalate